U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07377656) titled 'Strengthening HPV Immunization Through EPI Leveraged Delivery' on Nov. 23, 2025.
Brief Summary: This is a randomized observer-blind placebo-controlled proof-of-concept study with the aim to assess the safety and tolerability, and the immunogenicity of a bivalent HPV vaccine administered in healthy infants and toddlers (9- and 15-month-olds) comparing them to an immune-bridging population of 15-20-year-old unmarried females in an open label study in Ghana at the Dodowa Health Research Center.
Study Start Date: Jan. 16
Study Type: INTERVENTIONAL
Condition:
HPV Vaccine
Intervention:
BIOLOGICAL: HPV vaccine
0.5 mL HPV Vaccine Inj...